Kristen Pettit, MD, obtained her medical degree from Chicago Medical School. She then completed her residency in internal medicine and fellowship in hematology and oncology at the University of Chicago.
Dr Pettit has been the recipient of multiple awards for her research, such as the Conquer Cancer Foundation/ASCO Young Investigator Award and the ASCPT Presidential Trainee Award. At present, Dr Pettit works as an Assistant Professor of Hematology and Oncology the University of Michigan.
Speaking on myeloid malignancies
Dr Pettit’s research interests lie in translational research for myeloid malignancies such as acute myeloid leukemia (AML) and myelofibrosis. She has been involved in the development of several drugs for the treatment of patients with AML. In addition, Dr Pettit is currently the Principal Investigator of a Phase II clinical trial investigating the novel agent IMG-7289 in patients with myelofibrosis.